相关实验视频
Updated: Jul 12, 2025

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
9.5K
用ISRIB调节未折叠的蛋白质反应减轻了西斯的耳毒性
bioRxiv : the preprint server for biology
|October 31, 2023
概括
西斯普拉丁化疗通过影响未折叠蛋白质反应 (UPR) 引起听力损失. 用ISRIB针对小鼠的UPR进行药物保护听力,而不会减少癌细胞死亡.
科学领域:
- 耳毒性研究研究
- 癌症化疗的副作用 癌症化疗的副作用
- 分子生物学分子生物学
背景情况:
- 西斯普拉丁化疗经常导致感觉神经听力损失,这是一个副作用,机制不太清楚.
- 目前预防耳毒性的策略集中在氧化应激和亡上,但像硫酸酸这样的治疗方法有局限性.
- 展开的蛋白质反应 (UPR) 和内细胞网膜 (ER) 的压力与听力损失和西斯普拉丁细胞毒性有关.
研究的目的:
- 调查UPR在西斯普拉丁诱导的耳毒性中所起的作用.
- 为了确定是否针对UPR可以防止因西斯丁引起的听力损失.
- 评估针对UPR的药物是否会影响西斯的抗癌疗效.
主要方法:
- 暴露于新生儿耳细胞和HEK细胞的西斯普拉丁和UPR调节药物,测量UPR标记物和细胞死亡.
- 使用体内小鼠模型来测试ISRIB对西斯普拉丁耳毒性的疗效.
- 评估ISRIB对头部和部状细胞癌 (HNSCC) 细胞中西斯丁细胞毒性的影响.
主要成果:
- 西斯普拉丁诱导了一种与UPR标记基因表达相关的双相细胞死亡反应.
- 在小鼠中,ISRIB治疗防止了西斯胺诱导的听力损失和毛细胞死亡.
- 与硫酸硫酸不同,ISRIB没有影响西斯普拉丁对HNSCC细胞的细胞毒性作用.
结论:
- UPR,特别是PERK/CHOP通路,与西斯的耳毒性有关.
- 通过ISRIB准亲细胞亡的PERK/CHOP通路,可以减轻西斯的耳毒性.
- 伊斯瑞布 (ISRIB) 提供了一种潜在的策略,用于开发可以预防听力损失的药物,而不会影响化疗的疗效.
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Unfolded Protein Response
4.7K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K
Riboswitches
8.1K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Translational Regulation
28
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
28
Transcriptional Regulation: Riboswitches
47
Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
47

